MRD (minimal/measurable residual disease) testing is changing the way doctors understand and monitor blood cancers.  In this episode, we talk with Dr. John Burke of the Rocky Mountain Cancer Center about how MRD testing works, what the results mean to patients and their care teams, and how ongoing clinical research is helping shape more personalized and hopeful approaches to treatment. 

Mentioned on this episode: 

• Minimal/Measurable Residual Disease (MRD) fact sheet
• Minimal/Measurable Residual Disease (MRD) chart
• CAR T-cell therapy

Additional LLS Support Resources: 

• Free Nutrition Consultations
• Information Specialists 
• Free telephone/web patient programs 
• Clinical Trial Support Center
• Advocacy and Public Policy
• Free booklets 
• Financial support
• Young Adult Resources
• Support groups 
• Survivorship Workbook
• Community
• Caregiver support 
• Caregiver Workbook
• Mental Health Resources

Supported by Adaptive Biotechnologies Corporation and Allogene Therapeutics.

The post MRD Explained: What it Means for You and Your Care first appeared on The Bloodline with Blood Cancer United Podcast.